LEXINGTON, Mass., May 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that the Company will report its first quarter 2026...
Hence then, the article about curis to report first quarter 2026 financial and operating results and host conference call and webcast on may 12 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 )
Also on site :
- SEC recruiting update: Every team’s ranking entering July
- Iran raises the stakes – no negotiations without these conditions
- Legally Blonde Prequel Series Elle Is 'Officially Canon' With The Movie, EPs Confirm — Here's How They Made Sure 'Everything Tracked'